Fingertip test may rival blood test in sepsis care

NCT ID NCT06727318

Completed Knowledge-focused Sponsor: Gulhane Training and Research Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 192 adults with septic shock to see if a simple finger-pressure test (capillary refill time) could predict outcomes as well as a standard blood test (lactate level). Researchers measured both at the same time and tracked which patients got worse or died within 28 days. The goal was to find a faster, cheaper way to monitor these critically ill patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors use a simple bedside test (capillary refill) to quickly assess septic shock patients, potentially improving care.
What could go wrong: This is an observational study, not a treatment trial. It only looks at correlations, so it cannot prove that using capillary refill improves survival.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPOTENSIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypotensive disorder infectious disease with sepsis lactic acidosis Sepsis Toxemia toxic shock syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPOTENSIVE LACTATE LACTIC ACIDOSIS SEPSIS SHOCK, SEPTIC

Contacts and locations

Locations

Healty Sciences University Gulhane Training and Research Hospital

Ankara, KEÇİÖREN, 06010, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.